Methods/design
This was a multicenter, single-arm, open-label, phase Ib expansion cohort study conducted at seven hospitals in China. The study was approved by the ethics committee of each participating hospital. Written informed consent was obtained from each patient. This study was registered with clinicalTrials.gov, NCT02929290.